Veterinary Reference Laboratory Market Report 2030 [Latest]

Industry Report and Statistics (Facts & Figures) - Sales & Demand by Technology & Application

The global veterinary reference laboratory market will witness a robust CAGR of 11.2 %, valued at $3.74 billion in 2021, expected to appreciate and reach $9.74 billion by 2030, confirms Strategic Market Research. Over the next ten years, North America will continue to show its domination in the industry with the largest revenue share. In harmonizing laboratory diagnostic tests and the standardization of veterinary vaccinations, reference laboratories are significant, especially crucial to fostering trust among international commercial partners. Veterinary reference laboratories effectively prevent zoonotic infections, promote animal health and welfare, and safe food production. Zoonotic infections are serious public health problems, especially in tropical areas lacking healthcare facilities and financial resources. Brucellosis, TB, and anthrax are bacterial infections, whereas yellow fever, HIV infection, rabies, and measles are viral diseases (toxoplasmosis, cysticercosis, and leishmaniasis) that occur due to zoonotic infections. The risk of spreading zoonotic illnesses via mosquitoes, ticks, fleas, and animal interactions is extremely high. According to Global Animal Health Association, 60 % of diseases in the world are zoonotic, meaning they may transfer from animals to humans, and the great majority originate in wildlife. Rabies and Lyme disease are examples of zoonotic infections. 5,000 animal rabies cases are reported to the CDC yearly, with over 90% occurring in animals. Due to the rise of animal illnesses worldwide, veterinary reference laboratories have increased. In addition, the rise in pet adoption, increasing animal healthcare costs, the growing demand for animal-derived food products, and the necessity for pet insurance are driving the market growth significantly.

Key Market Drivers - Increase in Population of Companion Animals, Rapid Urbanization, and Increasing Public Awareness

Significant growth in the number of companion animals has been recorded in recent years. The number of dogs and cats and the percentage of families with dogs or cats have climbed. Shelters are a significant source of new pet adoption, accounting for 40% of cats and 38% of dogs in 2020. According to the National Pet Owners Survey 2021–2022 conducted by the American Pet Products Association (APPA), 70 % of US homes which is equivalent to approximate 90.5 million families, own a pet.

Also, rapid urbanization has led to a rise in the per capita expenditure on animal health because of the increasing adoption of companion animals in the urban population. Furthermore, the increasing public awareness of animal health is also propelling the veterinary reference laboratory market. According to the findings of the North American Pet Health Insurance Association (NAPHIA), gross written premiums for pet health insurance in the United States reached $1.99 billion in 2020, with an increment of 27.5 % from $1.56 billion in 2019. The industry had observed an average annual growth rate of around 24.2 % from 2016 to 2020. By 2020, the total number of pets insured had risen to 3.1 million.

Market Restraints - High Price of Pet Care and Less Number of Veterinarians

The veterinary diagnostics industry is being hampered by the high price of pet care and imaging devices and the scarcity of veterinarians.

Opportunities - Increasing Uses of Immunodiagnostic Kits, Rising Demand for Animal-derived Food, and Investment in Emerging Economies

The industry growth is likely to increase as more immunodiagnostic kits for veterinary applications are used in applications such as sophisticated diagnostic platforms and immunoassay formats. In addition, over the projected period, rising demand for animal-derived food and companion & livestock animals is expected to boost the demand for veterinary health immunodiagnostics tests. Total animal/animal product receipts are expected to increase by $8.6 billion (5.2 %) from 2020 levels, with the rise in receipts for cattle/calves, hogs, and broilers. Moreover, according to USDA's chief economist, total crop receipts are anticipated to grow by $11.8 billion (5.8%) from 2020, driven by increased receipts for soybeans and corn on increased production and high prices. Between 2021 and 2030, global beef, pig, and poultry consumption is expected to increase by 8.9%, 17.3%, and 16.3 %, respectively. China is responsible for the highest consumption of all three meat commodities, accounting for 73% of the expected growth in pork demand.

Several global companies focus on their investments in emerging economies to extend their global footprint and increase revenue. In the last three years, requests for World Bank support for livestock operations have surged from an average of $150 million in annual financing commitments at the start of the decade to almost $700 million in every new lending year. The World Bank currently has $1.9 billion in active livestock investments. Africa, South and Central Asian countries are using these investments to optimize livestock operations. As a result, it is projected to stimulate demand for veterinary reference laboratory services in the upcoming years.

Moreover, rapid development in various veterinary lab equipment and methodologies such as endocrinology, clinical immunology, pcr testing, microbiology, pharmacology, drug testing, pancreas testing, infectious diseases, hematology, parasitology, urinalysis, nutrition, genetics, cytopathology, SDMA test, veterinary laboratory medicine CBC testing, antigen testing followed by accurate and precise results from these tests are also leading to a higher adaptation rate. Hence it will create a huge growth opportunity for the market in the near future. For example, In-vitro fertilization (IVF) in cattle has been greatly improved by adopting the method proposed in the research done by the University of Kent, Nottingham, and L'AllianceBoviteq Inc. The IVF research method looks for features like disease resistance and food conversion (less waste) with increased meat and milk output in embryos. This technique is expected to significantly minimize cow pregnancy complications, enhance overall meat and milk production, and serve as a platform for future IVF research in humans.

Veterinary Reference Laboratory Market Analysis Of Different Segments Covered in the Report

Based on Technology:

Clinical Chemistry

Hematology

Immunodiagnostics

ELISA

Lateral Flow Rapid Tests

Others

Molecular Diagnostics

PCR

Microassays

Others

Others

Based on Application:

Clinical Pathology

Toxicology

Productivity Testing

Others

Based on Animal Type:

Livestock Animals

Companion Animals

Regional Coverage Analysis

North America

United States

Canada

Rest of North America

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Rest of Asia-Pacific

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Rest of Europe

Latin America

Brazil

Mexico

Rest of LAMEA

Segments Analysis & Insights

Based on the technology, the Clinical Chemistry category has the biggest revenue share due to its various applications in illness diagnosis and monitoring. CDC reported that zoonotic illnesses are relatively more infectious in the United States and globally. According to scientists, more than 6 out of every ten recognized infectious diseases in humans are transferred by animals, and animals carry 3 out of every four new or emerging infectious diseases in humans. Moreover, the global immunodiagnostics segment is poised to grow at a record CAGR of 8.3%.

Based on the application, in 2020, the Clinical Pathology segment of the market held the greatest share. Increased pathology tests drive the need for diagnostic devices and consumables for clinical pathology applications. Because of the increased need for toxicology testing services, the toxicology segment is expected to rise significantly in the upcoming years. In addition, strict food safety norms are likely to encourage the implementation of these tests to sustain veterinary and human wellness.

Companion Animals accounted for the biggest proportion of the industry share in the veterinary reference laboratory market based on the animal type. Also, this category is expected to have the highest CAGR during the projection period. The European Pet Food Industry reported that 88 million European families (38 %) own a pet. Approximately 110 million cats, 90 million dogs, 52 million birds, 30 million small mammals, 15 million aquariums, and 9 million reptiles are there in the United States, resulting in yearly pet food sales of $21.8 billion. The expanding adoption of companion animals, increasing disposable incomes, increased willingness of companion animal owners to spend more on animal health, and increasing frequency of zoonotic illnesses contribute to this segment's significant share and rapid growth rate.

Based on the region, North America will continue to have the highest industry share in terms of revenue over the next ten years due to the improved healthcare infrastructures, major market competitors, and high healthcare spending. The US Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) funded more than USD 16.3 million in 64 projects with states, colleges, and other partners to expand their animal health programs in December 2021. Animal health helps defend and preserve the US export market while keeping foreign animal diseases out of the country and helps expand rural America's export potential to grab the new and better industry. Due to the construction of veterinary reference laboratories by key global companies, increased animal healthcare expenditures, and unmet clinical requirements, the Asia Pacific region is expected to grow at a rapid growth rate.

Veterinary Reference Laboratory Market Report Coverage

Report Attribute

Details

Forecast Period

2021 - 2030

Market size value in 2021

USD 3.74 billion

Revenue forecast in 2030

USD 9.47 billion

Growth rate

CAGR of 11.2 %

The base year for estimation

2021

Historical data

2017 – 2020

Unit

USD Billion, CAGR (2021 - 2030)

Segmentation

By Technology, By Application, By Animal Type, By Region.

By Technology

Clinical Chemistry, Haematology, Immunodiagnostics, Molecular Diagnostics, Others

By Application

Clinical Pathology, Toxicology, Productivity Testing, Others

By Animal Type

Livestock Animals, Companion Animals

By Region

North America, Europe, Asia Pacific, LAMEA

Country Scope

US, Mexico, Canada, Germany, UK, France, China, Japan, India etc.

Company Usability Profiles

Boehringer Ingelheim, GD Animal Health, Zoetis Inc., Neogen Corporation, Laboklin GmbH, Synlab International GmbH, Heska Corporation, Virbac, Thermo Fisher Scientific, Inc.

Pricing and purchase options

Customized buying options are available to meet your exact research needs.

Global Veterinary Reference Laboratory Market Analysis Of Competitive Landscape

The competitive landscape analysis gives an overview of some prominent players operating in the market. Product innovation and continued R&D operations to create sophisticated technologies have assisted the industry growth. In the target market, there are many significant companies, and some of the industry leaders are:

Idexx Laboratories, Inc.

VCA, Inc. (A Part of Mars Petcare)

Boehringer Ingelheim

GD Animal Health

Zoetis Inc.

Neogen Corporation

Laboklin GmbH

Synlab International GmbH

Heska Corporation

Virbac

Thermo Fisher Scientific, Inc.

Texas A&M Veterinary Medical Diagnostic Laboratory

University of Minnesota (Veterinary Diagnostic Laboratory)

Iowa State University (Veterinary Diagnostic Laboratory)

Vetnostics

IDVET

Protatek International Inc.

Animal and Plant Health Agency

Animal Health Diagnostic Center (Cornell University)

National Veterinary Services Laboratory Usda-Aphis

Washington Animal Disease Diagnostic Laboratory (Waddl)

Colorado State University (Veterinary Diagnostic Laboratories)

The Pirbright Institute

Friedrich-Loeffler-Institut (FLI)

Kansas State Veterinary Diagnostic Laboratory

Recent Developments:

On September 2021, Biotech Laboratories USA LLC ("Biotech"), a leading producer of quick assay diagnostics testing, was bought by Heska Corporation from Biotech Holdings USA, a leading global provider of sophisticated veterinary diagnostic and specialized products.

On July 2021, SpotLightePARR, a highly accurate and speedy molecular diagnostic test for canine lymphoma, was released by Vidium Animal Health. SpotLightePARR was the company's second diagnostic test after the September 2020 debut of Vidium's SearchLight DNATM, a genomics-based test that detects significant mutations in 120 key cancer genes in dogs. Vidium collaborated with the Translational Genomics Research Institute (TGen), a City of Hope affiliate, and Ethos Discovery to create SpotLightePARR.

On June 2021, The University of Minnesota Veterinary Diagnostic Laboratory began providing a new ELISA test to identify Mycoplasma hyopneumoniae antibodies in pig serum samples. Hipra Laboratories in Spain offered the test as "CIVTEST SUIS MHYO."

On January 2020, the development of a new quick digital cytology service was announced by IDEXX Laboratories, Inc., a significant leader in the worldwide veterinary diagnostics and software sector. The program connects veterinarians to the world's biggest network of veterinary clinical pathologists, allowing them to get cytology interpretations in less than two hours.

Various Devices that the Market Leaders are Manufacturing

Name

Feature

Key Player

FecalDx antigen testing

Many intestinal parasite infections are detected earlier than with fecal flotation, even when no eggs are present; a single test detects hookworms, roundworms, and whipworms.

Idexx

AlphaTRAK

It's a blood glucose monitoring system to keep track of the blood sugar levels of diabetic dogs, cats, and ferrets.

Zoetis

Cuattro Hub

It is a portable multi-modality device to perform ultrasound, full-body x-ray, dental x-ray, etc.

Heska

Frequently Asked Question About This Report

The global plasma protein therapeutics market is expected to grow at a compound annual growth rate (CAGR) of 7.1% from 2021 to 2030 to reach USD 50.4 billion by 2030.

The global veterinary reference laboratory market size was $3.74 Bn in 2021 and is likely to reach around $9.74 Bn by 2030, with a CAGR of 11.2%.

The global veterinary reference laboratory market is forecast to grow at a CAGR of 11.2 %.

The global veterinary reference laboratories market size was USD 3.74 billion 2021. It is predicted to reach USD 9.74 billion by 2030, with a CAGR of 11.2 % throughout the forecasted period.

Top industry players are Idexx Laboratories, Inc., VCA, Inc. (A Part of Mars Petcare), Boehringer Ingelheim, GD Animal Health, Zoetis Inc., Neogen Corporation, Laboklin GmbH, Synlab International GmbH, Heska Corporation, Virbac, Thermo Fisher Scientific, Inc.

Veterinary reference labs are facilities that provide a variety of important veterinary services, including illness diagnosis, treatment options determination, disease prevention, and disease monitoring.

Private, commercial reference laboratories with high-volume routine and speciality testing are the most common. Most tests are suggested by hospitals, doctors offices and other healthcare facilities such as nursing homes.

These laboratories are in charge of dealing with scientific and technological concerns related to the illnesses on the OIE lists, and they are centres of excellence that, in addition to performing disease research, seek to standardize diagnostic methodologies. Merck veterinary manual reference ranges list is one such standard list available in the market.

Healthcare organizations looking to enhance the usage of laboratory testing can benefit from reference laboratories unique resources. Knowledge, data, and cross-institutional interactions are examples of these resources. A deep scientific understanding of test performance, physiology, pertinent clinical research, and practice recommendations are among the skills required. Comparative ordering and outcome data from multiple universities are included in the data. Relationships between reference laboratory clients span healthcare delivery organizations organizational borders, allowing for more information and knowledge exchange.

Veterinary reference laboratory market trends are: • Increased adoption of companion animals, increased availability of advanced diagnostic tests, rising demand for pet insurance, and a growing focus on innovations in veterinary health care are likely to drive the global veterinary reference laboratories market. • The global veterinary reference laboratories market is being boosted by increased interest in veterinary health care, increased R & D activities in veterinary health care, and an increase in the number of veterinary reference laboratories.

The global veterinary reference laboratory market is expected to grow at a compound annual growth rate (CAGR) of 11.2% from 2021 to 2030 to reach USD 9.74 billion by 2030.

Sources

https://www.worldbank.org/en/topic/agriculture/brief/moving-towards-sustainability-the-livestock-sector-and-the-world-bank

https://www.emro.who.int/fr/about-who/rc61/zoonotic-diseases.html

https://www.americanpetproducts.org/press_industrytrends.asp

https://naphia.org/news/naphia-news/pet-insurance-market-continued-double-digit-growth/

https://www.nass.usda.gov/Newsroom/2022/03-31-2022.php

https://www.porkbusiness.com/markets/market-news/increased-stability-and-demand-expected-livestock-sector-meyer-says

1. Introduction

1.1. Study Objective

1.2. Market Definition

1.3. Study Scope

1.3.1. Markets Covered

1.3.2. Geographic Scope

1.3.3. Years Considered

1.3.4. Stakeholders

2. Research Methodology

2.1. Data Procurement

2.2. Paid Database

2.2.1. Secondary Data

2.2.1.1. Key Secondary sources

2.2.2. Primary Data

2.2.2.1 Primary sources

2.2.2.2. Key industry insights

2.2.2.3. Primary interviews with experts

2.2.2.4. Key primary respondent list

2.3. Market Size Estimation

2.4. Bottom-Up and Top-Down Approaches

2.4.1. Bottom-Up Approach

2.4.1.1. Approach for arriving at market size by bottom-up analysis

2.4.2. Top-Down Approach

2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis

2.5. Market Breakdown and Data Triangulation

2.6. Research Methodology

2.7. Risk Assessment

3. Executive Summary

3.1 Veterinary Reference Laboratory Market: Post-Covid-19

3.1.1 Actual Scenario

3.1.2 Pessimistic Scenario

3.1.3 Optimistic Scenario

3.1.4 Market Summary

4. Industry Outlook

4.1 Market Snapshot

4.2 Based on Technology

4.2.1 Based on Technology, 2021 – 2030 (USD Million)

4.3 Based on Application

4.3.1 Market, Based on Application, 2021-2030 (USD Million)

4.4 Based on Animal Type

4.4.1 Market, Based on Animal Type, 2021-2030 (USD Million)

4.5 By Region

4.5.1 Market, By Region, 2021-2030 (USD Million)

4.7 Value Chain Analysis

4.8 Market Variable Analysis

4.8.1 Market Drivers Analysis

4.8.2 Market Restraints Analysis

4.9 Business Environment Analysis Tool

4.9.1 Market PEST analysis

4.9.2 Market Porter’s analysis

4.10 Penetration & Growth Prospect Mapping

5. Market Dynamics

5.1. Introduction

5.2. Market Dynamics

5.2.1. Drivers

5.2.2. Restraints

5.2.3. Opportunities

5.2.4. Challenges

5.3. Impact of Covid-19 On Market

5.4. Value Chain Analysis

5.5. Ecosystem

5.6. Patent Analysis

5.7. Trade Analysis

5.8. Tariff Analysis

5.9. Case Study Analysis

5.10. Porter’s Five Forces Analysis

5.10.1 Threat of New Entrants

5.10.2 Threat of Substitutes

5.10.3 Bargaining Power of Buyers

5.10.4 Bargaining Power of Suppliers

5.10.5 Degree of Competition

5.11. By Product Analysis

5.11.1. Trends in By Product (2014-2020)

5.11.2. Trends in By Product (2021-2028)

5.12. Pricing Analysis

5.12.1. Average Price Trend Analysis (By region, By Countries)

6. Competitive & Vendor Landscape

6.1. Company Market Share Analysis

6.2. Manufacturers Veterinary Reference Laboratory Manufacturing Sites, Area Served, Product Payload

6.3. Market Competitive Situation and Trends

6.4. Manufacturers Mergers & Acquisitions, Expansion Plans

7. Global Market: Based on Technology

7.1. Introduction

7.2. Sales Volume & Revenue Analysis (2021-2030)

7.3. Clinical Chemistry

7.3.1. Clinical Chemistry market, 2021-2030 (USD Million)

7.4. Haematology

7.4.1. Haematology market, 2021-2030 (USD Million)

7.5. Immunodiagnostics

7.5.1. Immunodiagnostics market, 2021-2030 (USD Million)

7.5.1.1. ELISA market, 2021-2030 (USD Million)

7.5.1.2. Lateral Flow Rapid Tests market, 2021-2030 (USD Million)

7.6. Molecular Diagnostics

7.6.1. Molecular Diagnostics market, 2021-2030 (USD Million)

7.6.1.1. PCR market, 2021-2030 (USD Million)

7.6.1.2. Microassays market, 2021-2030 (USD Million)

7.6. Others

7.6.1. Others market, 2021-2030 (USD Million)

8. Global Market: Based on Application Segment Analysis

8.1. Introduction

8.2. Sales Volume & Revenue Analysis (2021-2030)

8.3. Clinical Pathology

8.3.1. Clinical Pathology Market, 2021-2030 (USD Million)

8.4. Toxicology

8.4.1. Toxicology Market, 2021-2030 (USD Million)

8.5. Productivity Testing

8.5.1. Productivity Testing Market, 2021-2030 (USD Million)

8.6. Others

8.6.1. Others market, 2021-2030 (USD Million)

9. Global Market: Based on Animal Type

9.1. Introduction

9.2. Sales Volume & Revenue Analysis (2021-2030)

9.3. Livestock Animals

9.3.1. Livestock Animals market, 2021-2030 (USD Million)

9.4. Companion Animals

9.4.1. Companion Animals market, 2021-2030 (USD Million)

10. Global Market: Regional Outlook

10.1 North America

10.1.1. North America Market, Based on Technology, 2021-2030 (USD Million)

10.1.2. North America Market, Based on Application, 2021-2030 (USD Million)

10.1.3. North America Market, Based on Animal Type, 2021-2030 (USD Million)

10.1.4. North America Market, By Country, 2021-2030 (USD Million)

10.1.4.1. U.S.

10.1.4.1.1. U.S. Market, Based on Technology, 2021-2030 (USD Million)

10.1.4.1.2. U.S. Market, Based on Application, 2021-2030 (USD Million)

10.1.4.1.3. U.S. Market, Based on Animal Type, 2021-2030 (USD Million)

10.1.4.1.3. U.S. Market, By Country, 2021-2030 (USD Million)

10.1.4.2. Canada

10.1.4.2.1. Canada Market, Based on Technology, 2021-2030 (USD Million)

10.1.4.2.2. Canada Market, Based on Application, 2021-2030 (USD Million)

10.1.4.2.3. Canada Market, Based on Animal Type, 2021-2030 (USD Million)

10.1.4.1.3. Canada. Market, By Country, 2021-2030 (USD Million)

10.2. Europe

10.2.1. Europe Market, Based on Technology, 2021-2030 (USD Million)

10.2.2. Europe Market, Based on Application, 2021-2030 (USD Million)

10.2.3. Europe Market, Based on Animal Type, 2021-2030 (USD Million)

10.2.4. Europe Market, By country, 2021-2030 (USD Million)

10.2.4.1 U.K.

10.2.4.1.1. U.K. Market, Based on Technology, 2021-2030 (USD Million)

10.2.4.1.2. U.K. Market, Based on Application, 2021-2030 (USD Million)

10.2.4.1.3. U.K. Market, Based on Animal Type, 2021-2030 (USD Million)

10.2.4. U.K. Market, By country, 2021-2030 (USD Million)

10.2.4.2. Germany

10.2.4.2.1. Germany Market, Based on Technology, 2021-2030 (USD Million)

10.2.4.2.2. Germany Market, Based on Application, 2021-2030 (USD Million)

10.2.4.2.3. Germany Market, Based on Animal Type, 2021-2030 (USD Million)

10.2.4.2.3 Germany Market, By country, 2021-2030 (USD Million)

10.2.4.3. France

10.2.4.3.1. France Market, Based on Technology, 2021-2030 (USD Million)

10.2.4.3.2. France Market, Based on Application, 2021-2030 (USD Million)

10.2.4.3.3. France Market, Based on Animal Type, 2021-2030 (USD Million)

10.2.4.2.3 France Market, By country, 2021-2030 (USD Million)

10.2.4.4. Rest of Europe

10.2.4.4.1. Rest of Europe Market, Based on Technology 2021-2030 (USD Million)

10.2.4.4.2. Rest of Europe Market, Based on Application, 2021-2030 (USD Million)

10.2.4.4.3. Rest of Europe Market, Based on Animal Type, 2021-2030 (USD Million)

10.2.4.4.4 Rest of Europe Market, By country, 2021-2030 (USD Million)

10.3. Asia Pacific

10.3.1. Asia Pacific Market, Based on Technology, 2021-2030 (USD Million)

10.3.2. Asia Pacific Market, Based on Application, 2021-2030 (USD Million)

10.3.3. Asia Pacific Market, Based on Animal Type, 2021-2030 (USD Million)

10.3.4. Asia Pacific Market, By country, 2021-2030 (USD Million)

10.3.4.1. China

10.3.4.1.1. China Market, Based on Technology, 2021-2030 (USD Million)

10.3.4.1.2. China Market, Based on Application, 2021-2030 (USD Million)

10.3.4.1.3. China Market, Based on Animal Type, 2021-2030 (USD

Million)

10.2.4.4.4 China Market, By country, 2021-2030 (USD Million)

10.3.4.2. India

10.3.4.2.1. India Market, Based on Technology, 2021-2030 (USD Million)

10.3.4.2.2. India Market, Based on Application, 2021-2030 (USD Million)

10.3.4.2.3. India Market, Based on Animal Type, 2021-2030 (USD Million)

10.2.4.4.4 India Market, By country, 2021-2030 (USD Million)

10.3.4.3. Japan

10.3.4.3.1. Japan Market, Based on Technology, 2021-2030 (USD Million)

10.3.4.3.2. Japan Market, Based on Application, 2021-2030 (USD Million)

10.3.4.3.3. Japan Market, Based on Animal Type 2021-2030 (USD Million)

10.2.4.4.4 Japan Market, By country, 2021-2030 (USD Million)

10.3.4.4. South Korea

10.3.4.4.1. South Korea Market, Based on Technology, 2021-2030 (USD Million)

10.3.4.4.2. South Korea Market, Based on Application, 2021-2030 (USD Million)

10.3.4.4.3. South Korea Market, Based on Animal Type, 2021-2030 (USD Million)

10.3.4.4.3. South Korea Market, By country, 2021-2030 (USD Million)

10.3.4.5. Rest of ASIA PACIFIC

10.3.4.5.1. Rest of ASIA PACIFIC Market, Based on Technology, 2021-2030 (USD Million)

10.3.4.5.2. Rest of ASIA PACIFIC Market, Based on Application, 2021-2030 (USD Million)

10.3.4.5.3. Rest of ASIA PACIFIC Market, Based on Animal Type, 2021-2030 (USD Million)

10.3.4.5.3. Rest of ASIA PACIFIC Market, By country , 2021-2030 (USD Million)

10.4. Latin America

10.4.1. Latin America Market, Based on Technology, 2021-2030 (USD Million)

10.4.2. Latin America Market, Based on Application, 2021-2030 (USD Million)

10.4.3. Latin America Market, Based on Animal Type, 2021-2030 (USD Million)

10.4.4. Latin America Market, By country, 2021-2030 (USD Million)

10.4.4.1. Brazil

10.4.4.1.1. Brazil Market, Based on Technology, 2021-2030 (USD Million)

10.4.4.1.2. Brazil Market, Based on Application, 2021-2030 (USD Million)

10.4.4.1.3. Brazil Market, Based on Animal Type, 2021-2030 (USD Million)

10.4.4.1.3. Brazil Market, By Country, 2021-2030 (USD Million)

10.4.4.2. Mexico

10.4.4.2.1. Mexico Market, Based on Technology, 2021-2030 (USD Million)

10.4.4.2.2. Mexico Market, Based on Application, 2021-2030 (USD Million)

10.4.4.2.3. Mexico Market, Based on Animal Type, 2021-2030 (USD Million)

10.4.4.2.3. Mexico Market, By Country, 2021-2030 (USD Million)

10.4.4.3. Rest of the Latin America

10.4.4.3.1. Rest of the Latin America Market, Based on Technology,2021-2030 (USD Million)

10.4.4.3.2. Rest of the Latin America Market, Based on Application, 2021-2030 (USD Million)

10.4.4.3.3. Rest of the Latin America Market, Based on Animal Type, 2021-2030 (USD Million)

10.4.4.3.3. Rest of the Latin America Market, By Country, 2021-2030 (USD Million)

10.5. MEA

10.5.1. MEA Market, Based on Technology, 2021-2030 (USD Million)

10.5.2. MEA Market, Based on Application, 2021-2030 (USD Million)

10.5.3. MEA Market, Based on Animal Type, 2021-2030 (USD Million)

10.5.4. MEA Market, by Country , 2021-2030 (USD Million)

11. Competitive Landscape

11.1 Idexx Laboratories Inc.

11.1.1. Company overview

11.1.2. Financial performance

11.1.3. Product Portfolio Analysis

11.1.4. Business Strategy & Recent Development

11.2. VCA Inc, (A Part of Mars Petcare).

11.2.1. Company overview

11.2.2. Financial performance

11.2.3. Product Portfolio Analysis

11.2.4. Business Strategy & Recent Development

11.3. Boehringer Ingelheim.

11.3.1. Company overview

11.3.2. Financial performance

11.3.3. Product Portfolio Analysis

11.3.4. Business Strategy & Recent Development

11.4. GD Animal Health.

11.4.1. Company overview

11.4.2. Financial performance

11.4.3. Product Portfolio Analysis

11.4.4. Business Strategy & Recent Development

11.5. Zoetis Inc.

11.5.1. Company overview

11.5.2. Financial performance

11.5.3. Product Portfolio Analysis

11.5.4. Business Strategy & Recent Development

11.6. Neogen Corporation.

. 11.6.1. Company overview

11.6.2. Financial performance

11.6.3. Product Portfolio Analysis

11.6.4. Business Strategy & Recent Development

11.7. Laboklin GmbH.

11.7.1. Company overview

11.7.2. Financial performance

11.7.3. Product Portfolio Analysis

11.7.4. Business Strategy & Recent Development

11.8. Synlab International GmbH.

11.8.1. Company overview

11.8.2. Financial performance

11.8.3. Product Portfolio Analysis

11.8.4. Business Strategy & Recent Development

11.9. Heska Corporation.

11.9.1. Company overview

11.9.2. Financial performance

11.9.3. Product Portfolio Analysis